» Articles » PMID: 37096202

Natural Products As a Potential Source of Promising Therapeutics for COVID-19 and Viral Diseases

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A global pandemic has recently been observed due to the new coronavirus disease, caused by SARS-CoV-2. Since there are currently no antiviral medicines to combat the highly contagious and lethal COVID-19 infection, identifying natural sources that can either be viricidal or boost the immune system and aid in the fight against the disease can be an essential therapeutic support.

Methods: This review was conducted based on published papers related to the herbal therapy of COVID-19 by search on databases including PubMed and Scopus with herbal, COVID-19, SARS-CoV-2, and therapy keywords.

Results: To combat this condition, people may benefit from the therapeutic properties of medicinal plants, such as increasing their immune system or providing an antiviral impact. As a result, SARS-CoV-2 infection death rates can be reduced. Various traditional medicinal plants and their bioactive components, such as COVID-19, are summarized in this article to assist in gathering and debating techniques for combating microbial diseases in general and boosting our immune system in particular.

Conclusion: The immune system benefits from natural products and many of these play a role in activating antibody creation, maturation of immune cells, and stimulation of innate and adaptive immune responses. The lack of particular antivirals for SARS-CoV-2 means that apitherapy might be a viable option for reducing the hazards associated with COVID-19 in the absence of specific antivirals.

Citing Articles

The influence of spatial distribution and transcriptional regulation of secondary metabolites on the bioactivities of (Japanese lady bell).

Yoon S, Kim S, Hyun T Heliyon. 2024; 10(18):e37898.

PMID: 39323821 PMC: 11422053. DOI: 10.1016/j.heliyon.2024.e37898.

References
1.
Oyero O, Toyama M, Mitsuhiro N, Onifade A, Hidaka A, Okamoto M . SELECTIVE INHIBITION OF HEPATITIS C VIRUS REPLICATION BY ALPHA-ZAM, A SEED FORMULATION. Afr J Tradit Complement Altern Med. 2017; 13(6):144-148. PMC: 5412185. DOI: 10.21010/ajtcam.v13i6.20. View

2.
Malabed R, Hanashima S, Murata M, Sakurai K . Sterol-recognition ability and membrane-disrupting activity of Ornithogalum saponin OSW-1 and usual 3-O-glycosyl saponins. Biochim Biophys Acta Biomembr. 2017; 1859(12):2516-2525. DOI: 10.1016/j.bbamem.2017.09.019. View

3.
Merad M, Martin J . Author Correction: Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020; 20(7):448. PMC: 7265161. DOI: 10.1038/s41577-020-0353-y. View

4.
Khodadadi E, Maroufi P, Khodadadi E, Esposito I, Ganbarov K, Espsoito S . Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19). Microb Pathog. 2020; 146:104241. PMC: 7199731. DOI: 10.1016/j.micpath.2020.104241. View

5.
Ahmad M, Ahmad F, Ashraf S, Saad H, Wahab S, Khan M . An updated knowledge of Black seed ( Linn.): Review of phytochemical constituents and pharmacological properties. J Herb Med. 2020; 25:100404. PMC: 7501064. DOI: 10.1016/j.hermed.2020.100404. View